Given that ACBP is upregulated in several cancer types (supplementary Fig S2A) (The Cancer Genome Atlas database, TCGA), we tested ACBP-sensitivity in a panel of cell lines derived from medulloblastoma, lung, colorectal and breast cancers. Here, DBI is linked to breast carcinoma.